BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9509679)

  • 21. Pituitary macroadenoma: a case report and review.
    Herse P
    Clin Exp Optom; 2014 Mar; 97(2):125-32. PubMed ID: 23944182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Visual field defects in 169 cases of pituitary adenomas].
    Shen MQ; Ye W; Zhang YY; Chen J
    Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1074-9. PubMed ID: 20193428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pattern of visual impairment in patients with pituitary adenoma.
    Wang H; Sun W; Fu Z; Si Z; Zhu Y; Zhai G; Zhao G; Xu S; Pang Q
    J Int Med Res; 2008; 36(5):1064-9. PubMed ID: 18831902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA.
    Hisanaga S; Kakeda S; Yamamoto J; Watanabe K; Moriya J; Nagata T; Fujino Y; Kondo H; Nishizawa S; Korogi Y
    AJNR Am J Neuroradiol; 2017 Nov; 38(11):2067-2072. PubMed ID: 28912278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern visual evoked potentials represent an early index for the evolution of optic chiasma syndrome of tumoral etiology.
    Badiu C; Serbănescu A; Coculescu M
    Rom J Physiol; 1996; 33(1-4):91-100. PubMed ID: 9117342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual field defects in 23 acromegalic patients.
    Kan E; Kan EK; Atmaca A; Atmaca H; Colak R
    Int Ophthalmol; 2013 Oct; 33(5):521-5. PubMed ID: 23397103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optic nerve hyperintensity on T2-weighted images among patients with pituitary macroadenoma: correlation with visual impairment.
    Tokumaru AM; Sakata I; Terada H; Kosuda S; Nawashiro H; Yoshii M
    AJNR Am J Neuroradiol; 2006 Feb; 27(2):250-4. PubMed ID: 16484385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual status in suprasellar pituitary tumours.
    Kaur A; Banerji D; Kumar D; Sharma K
    Indian J Ophthalmol; 1995 Sep; 43(3):131-4. PubMed ID: 8822488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of microperimetry and contrast sensitivity test in the diagnosis of optic chiasm compression due to pituitary adenomas.
    Sarnat-Kucharczyk M; Kos-Kudła B; Kajdaniuk D; Mrukwa-Kominek E
    Endokrynol Pol; 2019; 70(3):241-247. PubMed ID: 30699232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vision-related quality of life in patients with pituitary adenoma.
    Okamoto Y; Okamoto F; Hiraoka T; Yamada S; Oshika T
    Am J Ophthalmol; 2008 Aug; 146(2):318-322. PubMed ID: 18538298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Influencing Visual Field Recovery after Transsphenoidal Resection of a Pituitary Adenoma.
    Lee DK; Sung MS; Park SW
    Korean J Ophthalmol; 2018 Dec; 32(6):488-496. PubMed ID: 30549473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
    Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
    Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineation of optic nerves and chiasm in close proximity to large suprasellar tumors with contrast-enhanced FIESTA MR imaging.
    Watanabe K; Kakeda S; Yamamoto J; Watanabe R; Nishimura J; Ohnari N; Nishizawa S; Korogi Y
    Radiology; 2012 Sep; 264(3):852-8. PubMed ID: 22771880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The VEP in evaluation of pituitary tumors.
    Pietrangeli A; Jandolo B; Occhipinti E; Carapella CM; Morace E
    Electromyogr Clin Neurophysiol; 1991 Apr; 31(3):163-5. PubMed ID: 2049991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinotopic organization of the visual cortex before and after decompression of the optic chiasm in a patient with pituitary macroadenoma.
    Chouinard PA; Striemer CL; Ryu WH; Sperandio I; Goodale MA; Nicolle DA; Rotenberg B; Duggal N
    J Neurosurg; 2012 Aug; 117(2):218-24. PubMed ID: 22680245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of the optic pathway in large pituitary adenoma on heavily T2 weighted MR images.
    Eda M; Saeki N; Fujimoto N; Sunami K
    Br J Neurosurg; 2002 Feb; 16(1):21-9. PubMed ID: 11926461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Criteria for early detection of temporal hemianopia in asymptomatic pituitary tumor.
    Fujimoto N; Saeki N; Miyauchi O; Adachi-Usami E
    Eye (Lond); 2002 Nov; 16(6):731-8. PubMed ID: 12439668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The natural course of non-functioning pituitary adenomas].
    Wolffenbuttel BH; van den Berg G; Hoving EW; van der Klauw MM
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2537-43. PubMed ID: 19174932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender-related differences in non-functioning pituitary adenomas.
    Schaller B
    Neuro Endocrinol Lett; 2003 Dec; 24(6):425-30. PubMed ID: 15073569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive model for recovery of visual field after surgery of pituitary adenoma.
    Lee J; Kim SW; Kim DW; Shin JY; Choi M; Oh MC; Kim SM; Kim EH; Kim SH; Byeon SH
    J Neurooncol; 2016 Oct; 130(1):155-164. PubMed ID: 27476080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.